MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver

Mutagenesis

Volumn 27, Issue 1, 2012, Pages 59-66

  Chen, Tao ^a   Li, Zhiguang ^a   Yan, Jian ^a   Yang, Xi ^a   Salminen, William ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; CARCINOGEN; MICRORNA; PYRROLIZIDINE ALKALOID; RIDDELLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENOTOXICITY; HEPATITIS; HEPATOMEGALY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; MICROARRAY ANALYSIS; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; CARCINOGENS; CLUSTER ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER; LIVER NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS; PYRROLIZIDINE ALKALOIDS; RATS; RATS, INBRED F344; RATS, TRANSGENIC; RNA;

ANIMALIA; MUS; RATTUS;

EID: 84555186910     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger060     Document Type: Article

References (61)

1. Roeder, E. and Wiedenfeld, H. (2009) Pyrrolizidine alkaloids in medicinal plants of Mongolia, Nepal and Tibet. Pharmazie, 64, 699-716.
2. Roeder, E. (2000) Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie, 55, 711-726.
3. Roeder, E. (1995) Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie, 50, 83-98.
4. Fletcher, M. T., McKenzie, R. A., Blaney, B. J. and Reichmann, K. G. (2009) Pyrrolizidine alkaloids in Crotalaria taxa from northern Australia: Risk to grazing livestock. J. Agric. Food Chem., 57, 311-319.
5. Fowler, M. E. (1968) Pyrrolizidine alkaloid poisoning in calves. J. Am. Vet. Med. Assoc., 152, 1131-1137.
6. Seaman, J. T. (1987) Pyrrolizidine alkaloid poisoning of sheep in New South Wales. Aust. Vet. J., 64, 164-167.
7. Seaman, J. T. (1978) Pyrrolizidine alkaloid poisoning of horses. Aust. Vet. J., 54, 150. (Pubitemid 8357075)
8. Edgar, J. A., Colegate, S. M., Boppre, M. and Molyneux, R. J. (2011) Pyrrolizidine alkaloids in food: A spectrum of potential health consequences. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess., 28, 308-324.
9. Pavlica, D. and Samuel, I. (1970) Primary carcinoma of the liver in Ethiopia. A study of 38 cases proved at post-mortem examination. Br. J. Cancer, 24, 22-29.
10. Schoental, R. (1968) Toxicology and carcinogenic action of pyrrolizidine alkaloids. Cancer Res., 28, 2237-2246.
11. Williams, A. O., Edington, G. M. and Obakponovwe, P. C. (1967) Hepatocellular carcinoma in infancy and childhood in Ibadan, Western Nigeria. Br. J. Cancer, 21, 474-482.
12. Schoental, R. and Coady, A. (1968) The hepatotoxicity of some Ethiopian and East African plants, including some used in traditional medicines. East Afr. Med. J., 45, 577-580.
13. Chan, P. C., Mahler, J., Bucher, J. R., Travlos, G. S. and Reid, J. B. (1994) Toxicity and carcinogenicity of riddelliine following 13 weeks of treatment to rats and mice. Toxicon, 32, 891-908. (Pubitemid 24248616)
14. Hirono, I., Mori, H., Yamada, K., Hirata, Y. and Haga, M. (1977) Carcinogenic activity of petasitenine, a new pyrrolizidine alkaloid isolated from Petasites japonicus Maxim. J. Natl Cancer Inst., 58, 1155-1157. (Pubitemid 8073461)
15. Mattocks, A. R. and Cabral, J. R. (1982) Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues. Cancer Lett., 17, 61-66. (Pubitemid 13197835)
16. Schoental, R. and Head, M. A. (1957) Progression of liver lesions produced in rats by temporary treatment with pyrrolizidine (senecio) alkaloids, and the effects of betaine and high casein diet. Br. J. Cancer, 11, 535-544.
17. Chen, T., Mei, N. and Fu, P. P. (2010) Genotoxicity of pyrrolizidine alkaloids. J. Appl. Toxicol., 30, 183-196.
18. Xia, Q., Chou, M. W., Kadlubar, F. F., Chan, P. C. and Fu, P. P. (2003) Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Chem. Res. Toxicol., 16, 66-73. (Pubitemid 36139412)
19. Yang, Y. C., Yan, J., Doerge, D. R., Chan, P. C., Fu, P. P. and Chou, M. W. (2001) Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo. Chem. Res. Toxicol., 14, 101-109. (Pubitemid 32064380)
20. Chou, M. W., Jian, Y., Williams, L. D., Xia, Q., Churchwell, M., Doerge, D. R. and Fu, P. P. (2003) Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid. Chem. Res. Toxicol., 16, 1130-1137. (Pubitemid 37163219)
21. Chou, M. W., Yan, J., Nichols, J., Xia, Q., Beland, F. A., Chan, P. C. and Fu, P. P. (2003) Correlation of DNA adduct formation and riddelliineinduced liver tumorigenesis in F344 rats and B6C3F(1) mice. Cancer Lett., 193, 119-125. (Pubitemid 36428892)
22. Chan, P. C., Haseman, J. K., Prejean, J. D. and Nyska, A. (2003) Toxicity and carcinogenicity of riddelliine in rats and mice. Toxicol Lett., 144, 295-311. (Pubitemid 36966714)
23. Mirsalis, J. C. (1987) In vivo measurement of unscheduled DNA synthesis and S-phase synthesis as an indicator of hepatocarcinogenesis in rodents. Cell Biol. Toxicol., 3, 165-173. (Pubitemid 17126181)
24. Mirsalis, J. C., Steinmetz, K. L., Blazak, W. F. and Spalding, J. W. (1993) Evaluation of the potential of riddelliine to induce unscheduled DNA synthesis, S-phase synthesis, or micronuclei following in vivo treatment with multiple doses. Environ. Mol. Mutagen., 21, 265-271. (Pubitemid 23116658)
25. Chan, P. (1993) NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice. Toxic. Rep. Ser., 27, 1-9.
26. NTP (2003) Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol. Program Tech. Rep. Ser., 03-4442, 1-280.
27. Mei, N., Heflich, R. H., Chou, M. W. and Chen, T. (2004) Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats. Chem. Res. Toxicol., 17, 814-818. (Pubitemid 38856342)
28. Hong, H. L., Ton, T. V., Devereux, T. R., Moomaw, C., Clayton, N., Chan, P., Dunnick, J. K. and Sills, R. C. (2003) Chemical-specific alterations in ras, p.53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol. Appl. Pharmacol., 191, 227-234. (Pubitemid 37108686)
29. Chen, T. (2010) The role of microRNA in chemical carcinogenesis. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 28, 89-124.
30. Chen, L., Mei, N., Yao, L. and Chen, T. (2006) Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats. Toxicol. Lett., 165, 250-256.
31. Mengs, U., Lang, W. and Poch, I. (1982) The crcinogenic action of aristolochic acid in rats. Arch. Toxicol., 51, 109-119.
32. Fang, H., Harris, S. C., Su, Z., Chen, M., Qian, F., Shi, L., Perkins, R. and Tong, W. (2009) ArrayTrack: An FDA and public genomic tool. Methods Mol. Biol., 563, 379-398.
33. Tong, W., Cao, X., Harris, S. et al. (2003) ArrayTrack-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for toxicological research. Environ. Health Perspect., 111, 1819-1826. (Pubitemid 37526962)
34. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X. and Li, T. (2009) miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res., 37, D105-D110.
35. NTP (2008) Final report on carcinogens background document for riddelliine. Rep. Carcinog. Backgr. Doc., 8-5977, i-104.
36. Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. (Pubitemid 40094598)
37. Li, Z., Fuscoe, J. C. and Chen, T. (2011) MicroRNAs and their predicted target messenger RNAs are deregulated by exposure to a carcinogenic dose of comfrey in rat liver. Environ. Mol. Mutagen., 52, 469-478.
38. Li, Z., Branham, W. S., Dial, S. L., Wang, Y., Guo, L., Shi, L. and Chen, T. (2010) Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea. BMC Genomics, 11, 609.
39. Ross, J. A., Blackman, C. F., Thai, S. F., Li, Z., Kohan, M., Jones, C. P. and Chen, T. (2010) A potential microRNA signature for tumorigenic conazoles in mouse liver. Mol. Carcinog., 49, 320-323.
40. Mengs, U. (1988) Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol., 61, 504-505.
41. Chen, T., Li, Z., Mei, N. and Guo, L. (2009) MicroRNA expression and genomic gene expression, rather than DNA adduct and mutation induction, Indicate the carcinogenic tissue of aristolochic acid in rat. Environ. Mol. Mutagen., 50, 547-547.
42. Chen, T., Guo, L., Zhang, L., Shi, L. M., Fang, H., Sun, Y. M., Fuscoe, J. C. and Mei, N. (2006) Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics, 7 (Suppl. 2), S20.
43. Mei, N., Chou, M. W., Fu, P. P., Heflich, R. H. and Chen, T. (2004) Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats. Cancer Lett., 215, 151-158. (Pubitemid 39370032)
44. Chou, M. W., Yan, J., Nichols, J., Xia, Q., Beland, F. A., Chan, P. C. and Fu, P. P. (2003) Correlation of DNA adduct formation and riddelliineinduced liver tumorigenesis in F344 rats and B6C3F(1) mice. Cancer Lett., 193, 119-125. (Pubitemid 36428892)
45. Chen, D. H., Li, Z. and Chen, T. (2011) Increased expression of miR-34a in mouse spleen one day after exposure to N-ethyl-N-nitrosourea. Appl. J. Toxicol, 31, 496-498.
46. Li, Z., Shi, L., Pearce, M., Wang, Y., Guo, L., Branham, W. S. and Chen, T. (2009) Time-course study of microRNA gene expression in liver of mice treated with one dose of N-ethyl-N-nitrosourea. Environ. Mol. Mutagen., 50, 558-558.
47. Pogribny, I. P., Muskhelishvili, L., Tryndyak, V. P. and Beland, F. A. (2009) The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p.53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol., 235, 305-311.
48. Davidson, L. A., Wang, N., Shah, M. S., Lupton, J. R., Ivanov, I. and Chapkin, R. S. (2009) n-3 Polyunsaturated fatty acids modulate carcinogendirected non-coding microRNA signatures in rat colon. Carcinogenesis, 30, 2077-2084.
49. Pogribny, I. P., Tryndyak, V. P., Boyko, A., Rodriguez-Juarez, R., Beland, F. A. and Kovalchuk, O. (2007) Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat. Res., 619, 30-37. (Pubitemid 46602445)
50. Ilnytskyy, Y., Zemp, F. J., Koturbash, I. and Kovalchuk, O. (2008) Altered microRNA expression patterns in irradiated hematopoietic tissues suggest a sex-specific protective mechanism. Biochem. Biophys. Res. Commun., 377, 41-45.
51. Guessous, F., Zhang, Y., Kofman, A., Catania, A., Li, Y., Schiff, D., Purow, B. and Abounader, R. (2010) microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle, 9, 1031-1036.
52. Hermeking, H. (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ., 17, 193-199.
53. He, L., He, X., Lim, L. P. et al. (2007) A microRNA component of the p.53 tumour suppressor network. Nature, 447, 1130-1134. (Pubitemid 47014436)
54. Mei, N., Arlt, V. M., Phillips, D. H., Heflich, R. H. and Chen, T. (2006) DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat. Res. Fund. Mol. M., 602, 83-91. (Pubitemid 44693560)
55. Yamakuchi, M., Ferlito, M. and Lowenstein, C. J. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. U S A, 105, 13421-13426.
56. Bommer, G. T., Gerin, I., Feng, Y. et al. (2007) p.53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol., 17, 1298-1307. (Pubitemid 47176893)
57. Tazawa, H., Tsuchiya, N., Izumiya, M. and Nakagama, H. (2007) Tumorsuppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. U S A, 104, 15472-15477. (Pubitemid 47502941)
58. Fu, P. P., Xia, Q., Lin, G. and Chou, M. W. (2004) Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab. Rev., 36, 1-55. (Pubitemid 38387834)
59. Mei, N., Guo, L., Fu, P. P., Heflich, R. H. and Chen, T. (2005) Mutagenicity of comfrey (Symphytum Officinale) in rat liver. Br. J. Cancer, 92, 873-875. (Pubitemid 40462632)
60. Mei, N., Guo, L., Zhang, L. et al. (2006) Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale). BMC Bioinformatics, 7 (Suppl. 2), S16.
61. Guo, L., Mei, N., Dial, S., Fuscoe, J. and Chen, T. (2007) Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver. BMC Bioinformatics, 8 (Suppl. 7), S22.